Clinical Information
patient
|
XJ207806 |
Age
|
35 |
Gender
|
M |
Genotype
|
HBV_gtC,HBV_gtB |
Diagnosis
|
hepatocellular carcinoma |
HBV DNA
|
3530000IU/ml |
HBeAg
|
1 |
AFP(ng/ml)
|
>1210 |
PLT(log IU/mL)
|
321 |
HBcAb
|
1 |
HBsAb
|
0 |
HBeAb
|
0 |
HBsAg
|
1 |
ctDNA concentration
|
0.5426 |
marker
|
ctDNA+ |
Hospital
|
Eastern Hepatobiliary Surgery Hospital, Shanghai |
HBsAg (IU/ml)
|
>250 |
BCLC
|
C |
ACJJ
|
II |
Tumor maximum size
|
12 |
Tumor count
|
1 |
MVI
|
M2 |
AFP-L3
|
10.1 |
PIVKA-II (mAU/ml)
|
29136 |
CA199 (U/ml)
|
9.3 |
Cirrhosis history
|
0 |
Fatty liver
|
0 |
Hepatic encephalopathy (1-3)
|
1 |
Ascites (1-3)
|
1 |
TBIL (μmol/L)
|
1 |
ALB (g/L)
|
1 |
INR
|
1 |
Score
|
5 |
Child-Pugh stage
|
A |
HBV integration detection
|
Yes |
Integration number
|
123 |
HBV subtype frequency
|
0.0872438054450902,0.851973080452738 |
|
|